| Oxford Lane Capital Corp. Announces Full Redemption of 6.25% Series 2027 Term Preferred Stock |
Globe Newswire |
04/27 |
08:00 |
| OceanFirst Financial Corp. and Flushing Financial Corporation Announce Receipt of All Requisite Regulatory and Shareholder Approvals to Complete Proposed Merger and Annual Meeting Date |
Globe Newswire |
04/27 |
07:45 |
| Wheat Tortilla and Wraps Market to Cross $22.19 Billion by 2031, Fuelled by Rising popularity of Mexican Cusines: New Industry Research by The Insight Partners. |
Globe Newswire |
04/27 |
07:37 |
| New Research Reveals The Hidden Leadership Crisis Hiding In Plain Sight: 54% Of Leaders Are Producing Anxiety, Drift, And Disengagement – And Most Have No Idea |
Globe Newswire |
04/27 |
07:32 |
| urban-gro, Inc. (Nasdaq: UGRO) Issues Comprehensive Business Update: Strategic Transformation from Controlled Environment Agriculture to Sports, Media, and Experiential Platform; Restored Nasdaq Listing Compliance; Cricket Strategy Aligned with LA28 Olympic Inclusion and Growth of US Collegiate Cricket |
Globe Newswire |
04/27 |
07:30 |
| CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients |
Globe Newswire |
04/27 |
07:30 |
| BriaCell Announces Six Clinical Data Presentations at ASCO 2026 |
Globe Newswire |
04/27 |
07:30 |
| One Bullion Reports High Concentration of Gold During Artisanal Sampling Program at Vumba Project Which Yielded a 679 g/t Gold Sample |
Globe Newswire |
04/27 |
07:30 |
| Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer |
Globe Newswire |
04/27 |
07:30 |
| Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt |
Globe Newswire |
04/27 |
07:30 |
| Scorpio Tankers Inc. Announces New Credit Facility |
Globe Newswire |
04/27 |
07:28 |
| Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy |
Globe Newswire |
04/27 |
07:25 |
| Suja Life Announces Launch of Initial Public Offering |
Globe Newswire |
04/27 |
07:20 |
| Allot to Release First Quarter 2026 Results and Host Conference Call on May 12, 2026 |
Globe Newswire |
04/27 |
07:06 |
| HBT Financial, Inc. Announces First Quarter 2026 Financial Results |
Globe Newswire |
04/27 |
07:05 |
| CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer® |
Globe Newswire |
04/27 |
07:03 |
| Secura Bio Announces Journal of Clinical Oncology Publication of Final Results of Duvelisib PRIMO Phase 2 Trial in Relapsed/Refractory Peripheral T-cell Lymphoma |
Globe Newswire |
04/27 |
07:00 |
| Verizon’s Transformation Actions Deliver Growth & Profitability in 1Q26; Company Raises Adjusted EPS Guidance |
Globe Newswire |
04/27 |
07:00 |
| Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis |
Globe Newswire |
04/27 |
07:00 |
| Astec Announces Quarterly Dividend |
Globe Newswire |
04/27 |
07:00 |
| Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences |
Globe Newswire |
04/27 |
07:00 |
| Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240 |
Globe Newswire |
04/27 |
07:00 |
| Lakeland Financial Reports Record First Quarter Performance; Loan Growth of 5% and Revenue Growth of 9% Contribute to 32% Increase in Net Income to $26.5 Million |
Globe Newswire |
04/27 |
07:00 |
| Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis |
Globe Newswire |
04/27 |
07:00 |
| OTC Markets Group Welcomes WM Technology, Inc. to OTCQX |
Globe Newswire |
04/27 |
07:00 |
